SEC Form 4 · accession 0000914190-16-000826

Cardiovascular Systems Inc · CSII

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP Manufacturing & Operations

Period of report

Sep 7, 2016

Accepted (ET)

Sep 9, 2016 · 4:49 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001180145

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 7, 2016	M	5,969	$8.83	A	73,321	D
Common Stock^F3	Sep 7, 2016	S	5,969	$25.024	D	79,290	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F1	$8.83	Sep 7, 2016	M	4,675	D	—	Apr 17, 2017	Common Stock	4,675	30,910	D
Stock Option (right to buy)^F1	$8.83	Sep 7, 2016	M	1,294	D	—	Apr 17, 2017	Common Stock	1,294	0	D
Stock Option (right to buy)^F1	$7.90	holding	—	—	—	—	Jun 11, 2017	Common Stock	8,087	8,087	D
Stock Option (right to buy)^F1	$7.90	holding	—	—	—	—	Oct 8, 2017	Common Stock	12,940	12,940	D
Stock Option (right to buy)^F1	$12.15	holding	—	—	—	—	Dec 11, 2017	Common Stock	32,350	32,350	D
Stock Option (right to buy)^F1	$8.75	holding	—	—	—	—	Mar 1, 2019	Common Stock	8,087	8,087	D

F1Fully exercisable.
F2The option exercise and sales of the underlying shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.22 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.